FDA Import Refusal SCS-7690586-3/10002/1 — NOVO NORDISK
The FDA refused shipment SCS-7690586-3/10002/1 from NOVO NORDISK (Canada) on Oct 28, 2025. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Oct 28, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCP72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 75